A Phase 1, Open-Label Study to Investigate the Effect of Albuterol (Salbutamol) and Fluticasone on the Pharmacokinetics of Inhaled Technosphere® Insulin Inhalation Powder in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2012
At a glance
- Drugs Fluticasone propionate; Insulin; Salbutamol
- Indications Asthma; Chronic obstructive pulmonary disease; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MannKind Corporation
- 12 Jun 2012 Actual patient number is 13 according to ClinicalTrials.gov.
- 22 May 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 22 May 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.